title: Neoadjuvant therapy for HER2-positive early-stage breast cancer: the future is almost here.
authors.affiliation: University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, USA.
authors.forename: Hope S
authors.initials: HS
authors.lastname: Rugo
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases